These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hematopoietic growth factors as adjuncts to antiretroviral therapy. Miles SA. AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1073-80. PubMed ID: 1380256 [Abstract] [Full Text] [Related]
7. Potential use of human stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias. Miles SA, Lee K, Hutlin L, Zsebo KM, Mitsuyasu RT. Blood; 1991 Dec 15; 78(12):3200-8. PubMed ID: 1720698 [Abstract] [Full Text] [Related]
11. GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcoma. Scadden DT, Bering HA, Levine JD, Bresnahan J, Evans L, Epstein C, Groopman JE. Am J Clin Oncol; 1991 Dec 15; 14 Suppl 1():S40-4. PubMed ID: 2048563 [Abstract] [Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma. Scadden DT, Bering HA, Levine JD, Bresnahan J, Evans L, Epstein C, Groopman JE. J Clin Oncol; 1991 May 15; 9(5):802-8. PubMed ID: 2016623 [Abstract] [Full Text] [Related]
13. Use of recombinant interferons and hematopoietic growth factors in patients infected with human immunodeficiency virus. Mitsuyasu RT. Rev Infect Dis; 1991 May 15; 13(5):979-84. PubMed ID: 1720567 [Abstract] [Full Text] [Related]
14. Clinical potential of GM-CSF in HIV-infected patients: Studies at the Memorial Sloan Kettering Cancer Center. Krown SE, Paredes J, Gold JW, Bundow D, Anselmo W, O'Boyle K, Flomenberg N. Pathol Biol (Paris); 1992 Nov 15; 39(9):963. PubMed ID: 1538955 [No Abstract] [Full Text] [Related]